Arrowhead Pharmaceuticals to Present at Upcoming May 2019 Conferences May 02, 2019 07:30 AM Eastern Daylight Time https://www.businesswire.com/news/home/20190502005181/en/
Bank of America Merrill Lynch 2019 Health Care Conference ? Las Vegas, May 14-16, 2019
May 15, 8:40 a.m. PDT ? Christopher Anzalone, Ph.D., Arrowhead?s president and chief executive officer, will deliver a corporate presentation
Vascular Discovery: From Genes to Medicine 2019 Scientific Sessions (ATVB|PVD) ? Boston, May 14-16, 2019
May 15, 11:00 a.m. EDT ? So Wong, Ph.D., Arrowhead?s director of biology, will deliver a poster presentation titled, ?Reduction in Angiopoietin-Like Protein 3 via RNA Interference Improves Dyslipidemias and Hepatic Steatosis?
2019 National Lipid Association Scientific Sessions ? Aventura, FL, May 16-19, 2019
May 18, 11:25 a.m. EDT ? So Wong, Ph.D., Arrowhead?s director of biology, will deliver a poster presentation titled, ?Personalized Medicine for Dyslipidemias by RNA Interference-Mediated Reductions in Apolipoprotein C3 or Angiopoietin-Like Protein 3?
20th Annual B. Riley FBR Institutional Investor Conference ? Beverly Hills, May 22-23, 2019
May 23, 8:30 a.m. PDT ? Christopher Anzalone, Ph.D., Arrowhead?s president and chief executive officer, will participate in a fireside chat presentation with Mayank Mamtani, B. Riley FBR research analyst
|